I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.
metastatic castration-resistant prostate cancer
measurable disease
metastasis
metastatic disease
prostate cancer
- 0 views
- 19 Feb, 2024